Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of iguratimod versus nimesulide and placebo in rheumatoid arthritis
ChiCTR-TRC-10000850Phase 3Completed
- Sponsor
- Anhui Medical University
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of iguratimod in rheumatoid arthritis (RA) (3 arms), sponsored by Anhui Medical University. Primary endpoints: Morning stiffness, Pain and 6 more. Started Sep 2008; status: completed.
02
Drugs
iguratimod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR-TRC-10000850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000850.